ω-Hydroxylation of phylloquinone by CYP4F2 is not increased by α-tocopherol

Molecular Nutrition and Food Research

Volumn 57, Issue 10, 2013, Pages 1785-1793

  Farley, Sherry M ^a,b   Leonard, Scott W ^a   Taylor, Alan W ^a   Birringer, Marc ^c   Edson, Katheryne Z ^d   Rettie, Allan E ^d   Traber, Maret G ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c University of Applied Science Fulda   (Germany)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

5C and 7C aglycones; CEHC; CYP4F2; Phylloquinone; Tocopherol

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; CYP4F2 PROTEIN, HUMAN; CYTOCHROME P450; PHYTOMENADIONE; TOCOPHEROL;

5C- AND 7C-AGLYCONES; ANIMAL; ARTICLE; CEHC; CYP4F2; DIET SUPPLEMENTATION; DRUG EFFECT; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROXYLATION; IN VITRO STUDY; LIVER; LIVER MICROSOME; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY;

5C- AND 7C-AGLYCONES; CEHC; CYP4F2; PHYLLOQUINONE; TOCOPHEROL;

ADENOSINE TRIPHOSPHATE; ALPHA-TOCOPHEROL; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; DIETARY SUPPLEMENTS; HUMANS; HYDROXYLATION; LIVER; MALE; MICROSOMES, LIVER; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY; VITAMIN K 1;

EID: 84884938649     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200797     Document Type: Article

References (36)

1. Kalsotra, A., Strobel, H. W., Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism. Pharmacol. Ther. 2006, 112, 589-611.
2. Sontag, T. J., Parker, R. S., Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J. Biol. Chem. 2002, 277, 25290-25296.
3. Bardowell, S. A., Ding, X., Parker, R. S., Disruption of P450-mediated vitamin E hydroxylase activities alters vitamin E status in tocopherol supplemented mice and reveals extra-hepatic vitamin E metabolism. J. Lipid. Res. 2012, 53, 2667-2676.
4. McDonald, M. G., Rieder, M. J., Nakano, M., Hsia, C. K. et al., CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol. Pharmacol. 2009, 75, 1337-1346.
5. Birringer, M., Pfluger, P., Kluth, D., Landes, N. et al., Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells. J. Nutr. 2002, 132, 3113-3118.
6. Mustacich, D. J., Leonard, S. W., Patel, N. K., Traber, M. G., Alpha-tocopherol beta-oxidation localized to rat liver mitochondria. Free Radic. Biol. Med. 2010, 48, 73-81.
7. Harrington, D. J., Booth, S. L., Card, D. J., Shearer, M. J., Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J. Nutr. 2007, 137, 1763-1768.
8. Perez-Andreu, V., Roldan, V., Anton, A. I., Garcia-Barbera, N. et al., Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy. Blood 2009, 113, 4977-4979.
9. Caldwell, M. D., Awad, T., Johnson, J. A., Gage, B. F. et al., CYP4F2 genetic variant alters required warfarin dose. Blood 2008, 111, 4106-4112.
10. Gong, I. Y., Schwarz, U. I., Crown, N., Dresser, G. K. et al., Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation. PLoS One 2011, 6, e27808.
11. Bardowell, S. A., Stec, D. E., Parker, R. S., Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity. J. Nutr. 2010, 140, 1901-1906.
12. Major, J. M., Yu, K., Wheeler, W., Zhang, H. et al., Genome-wide association study identifies common variants associated with circulating vitamin E levels. Hum. Mol. Genet. 2011, 20, 3876-3883.
13. Swanson, J. E., Ben, R. N., Burton, G. W., Parker, R. S., Urinary excretion of 2, 7, 8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman is a major route of elimination of gamma-tocopherol in humans. J. Lipid. Res. 1999, 40, 665-671.
14. Leonard, S. W., Paterson, E., Atkinson, J. K., Ramakrishnan, R. et al., Studies in humans using deuterium-labeled α- and γ-tocopherol demonstrate faster plasma γ-tocopherol disappearance and greater γ-metabolite production. Free Radic. Biol. Med. 2005, 38, 857-866.
15. Yap, S. P., Yuen, K. H., Wong, J. W., Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J. Pharm. Pharmacol. 2001, 53, 67-71.
16. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy Press, Washington 2000.
17. Traber, M. G., Elsner, A., Brigelius-Flohe, R., Synthetic as compared with natural vitamin E is preferentially excreted as alpha-CEHC in human urine: studies using deuterated alpha-tocopheryl acetates. FEBS Lett. 1998, 437, 145-148.
18. Sontag, T. J., Parker, R. S., Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega-hydroxylase. J. Lipid Res. 2007, 48, 1090-1098.
19. Berkner, K. L., Vitamin K-dependent carboxylation. Vitam. Horm. 2008, 78, 131-156.
20. Traber, M. G., Vitamin E and K interactions: a 50-year-old problem. Nutr. Rev. 2008, 66, 624-629.
21. Niwa, T., Murayama, N., Yamazaki, H., Heterotropic cooperativity in oxidation mediated by cytochrome p450. Curr. Drug. Metab. 2008, 9, 453-462.
22. Meredith, C., Scott, M. P., Renwick, A. B., Price, R. J. et al., Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices. Xenobiotica 2003, 33, 511-527.
23. Olinga, P., Elferink, M. G., Draaisma, A. L., Merema, M. T. et al., Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. Eur. J. Pharm. Sci. 2008, 33, 380-389.
24. Birringer, M., Lington, D., Vertuani, S., Manfredini, S. et al., Proapoptotic effects of long-chain vitamin E metabolites in HepG2 cells are mediated by oxidative stress. Free Radic. Biol. Med. 2010, 49, 1315-1322.
25. Podda, M., Weber, C., Traber, M. G., Packer, L., Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols and ubiquinones. J. Lipid Res. 1996, 37, 893-901.
26. Mustacich, D. J., Leonard, S. W., Devereaux, M. W., Sokol, R. J. et al., Alpha-tocopherol regulation of hepatic cytochrome P450s and ABC transporters in rats. Free Radic. Biol. Med. 2006, 41, 1069-1078.
27. Tovar, A., Ameho, C. K., Blumberg, J. B., Peterson, J. W. et al., Extrahepatic tissue concentrations of vitamin K are lower in rats fed a high vitamin E diet. Nutr. Metab. (Lond). 2006, 3, 29-34.
28. Farley, S. M., Leonard, S. W., Labut, E. M., Raines, H. F. et al., Vitamin E decreases extra-hepatic menaquinone-4 concentrations in rats fed menadione or phylloquinone. Mol. Nutr. Food Res. 2012, 56, 912-922.
29. Suhara, Y., Watanabe, M., Motoyoshi, S., Nakagawa, K. et al., Synthesis of new vitamin K analogues as steroid and xenobiotic receptor (SXR) agonists: insights into the biological role of the side chain part of vitamin K. J. Med. Chem. 2011, 54, 4918-4922.
30. Harrington, D. J., Soper, R., Edwards, C., Savidge, G. F. et al., Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J. Lipid Res. 2005, 46, 1053-1060.
31. Hardwick, J. P., Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem. Pharmacol. 2008, 75, 2263-2275.
32. Fava, C., Montagnana, M., Almgren, P., Rosberg, L. et al., The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension 2008, 52, 373-380.
33. Deng, S., Zhu, G., Liu, F., Zhang, H. et al., CYP4F2 gene V433M polymorphism is associated with ischemic stroke in the male Northern Chinese Han population. Prog. Neuropsychopharmacol. Biol. Psychiatr. 2010, 34, 664-668.
34. Fu, Z., Nakayama, T., Sato, N., Izumi, Y. et al., A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men. Mol. Genet. Metab. 2009, 96, 145-147.
35. Booth, S. L., Golly, I., Sacheck, J. M., Roubenoff, R. et al., Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. Am. J. Clin. Nutr. 2004, 80, 143-148.
36. Glynn, R. J., Ridker, P. M., Goldhaber, S. Z., Zee, R. Y. et al., Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation 2007, 116, 1497-1503.